Stada Arzneimi Namen (STDAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 622,881 | 303,853 | 230,764 | 406,021 | N/A |
| Marketable Securities | 92,298 | 52,716 | 66,985 | 15,064 | N/A |
| Receivables | 943,320 | 803,641 | 695,239 | 619,501 | N/A |
| Inventories | 960,781 | 948,260 | 714,825 | 608,511 | N/A |
| Other current assets | 88,369 | 102,276 | 56,648 | 58,962 | 0 |
| TOTAL | $2,707,649 | $2,210,746 | $1,764,461 | $1,708,058 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 639,157 | 561,860 | 507,791 | 415,083 | N/A |
| Investments And Advances | 25,236 | 19,967 | 10,976 | 32,681 | 0 |
| Intangibles | 3,390,322 | 3,160,784 | 2,000,285 | 2,016,209 | 0 |
| Other Non-Current Assets | 48,679 | 53,082 | 39,044 | 32,479 | 0 |
| TOTAL | $4,103,393 | $3,795,693 | $2,558,096 | $2,496,451 | $N/A |
| Total Assets | $6,811,042 | $6,006,438 | $4,322,557 | $4,204,509 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 388,601 | 169,071 | 44,892 | 525,478 | N/A |
| Accounts payable and accrued liabilities | 711,183 | 604,929 | 463,707 | 372,110 | 0 |
| Other current liabilities | 603,497 | 658,799 | 827,323 | 519,588 | N/A |
| TOTAL | $1,759,910 | $1,496,362 | $1,402,409 | $1,511,328 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,200,057 | 2,948,272 | 1,394,163 | 1,155,474 | N/A |
| Other Non-Current Liabilities | 191,499 | 223,643 | 77,087 | 43,121 | 0 |
| TOTAL | $3,613,022 | $3,347,957 | $1,581,224 | $1,301,980 | $N/A |
| Total Liabilities | $5,372,932 | $4,844,318 | $2,983,633 | $2,813,309 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 191,769 | 185,155 | 181,541 | 191,428 | N/A |
| Retained earnings | 1,071,932 | 887,550 | 903,031 | 1,014,014 | N/A |
| Other shareholders' equity | -431,948 | -495,963 | -319,559 | -419,520 | 0 |
| TOTAL | $1,438,110 | $1,162,120 | $1,338,924 | $1,391,200 | $N/A |
| Total Liabilities And Equity | $6,811,042 | $6,006,438 | $4,322,557 | $4,204,509 | $0 |